CRVO
CervoMed Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.43
−4.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 53.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.60x
- Price / sales
- 113.90x
- Price / cash flow
- -1.31x
Enterprise value
- Enterprise value
- $11.8M
- EV / sales
- 36.59x
- EV / EBITDA
- -0.39x
- EV / EBIT
- -0.38x
- Market cap
- $36.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026